Crossmark

Dachaihu decoction alleviates septic liver injury by modulating the intestinal barrier dysfunction and suppressing the NF-κB/NLRP3/Caspase-1 signaling pathway

Crossref DOI link: https://doi.org/10.1186/s13020-026-01420-1

Published Online: 2026-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Zhen

Kao, Xingyu

Zhang, Lin

Huang, Na

Wang, Yi

Chen, Jingli

He, Mingfeng

Tang, Qi

Liang, Zhangrong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82374216)

Guangdong Province National Pilot Zone for Comprehensive Reform of Traditional Chinese Medicine Science and Technology Co-construction Project (GZY-KJGZY-KJS-GD-2025-076)
License Information

Text and Data Mining valid from 2026-06-16

Version of Record valid from 2026-06-16
More Information

Article History

Received: 12 January 2026

Accepted: 4 May 2026

First Online: 16 June 2026

Declarations

:

: All animal experimental procedures were approved by the Laboratory Animal Welfare and Ethics Committee of the School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine (no. ZYD-2023-101, No. ZYD-2023-102).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below